1. Prescott, Sara L, Umans, Benjamin D, Williams, Erika K, Brust, Rachael D, Liberles, Stephen D. 2020. An Airway Protection Program Revealed by Sweeping Genetic Control of Vagal Afferents. In Cell, 181, 574-589.e14. doi:10.1016/j.cell.2020.03.004. https://pubmed.ncbi.nlm.nih.gov/32259485/
2. Hua, Yinggang, Liu, Yanling, Li, Long, Liu, Guoyan. 2023. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation. In Open life sciences, 18, 20220078. doi:10.1515/biol-2022-0078. https://pubmed.ncbi.nlm.nih.gov/36879646/
3. Ueda, Yu, Li, Ronald H L, Nguyen, Nghi, Court, Michael H, Stern, Joshua A. 2021. A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy. In Scientific reports, 11, 12522. doi:10.1038/s41598-021-91372-3. https://pubmed.ncbi.nlm.nih.gov/34131167/
4. Timur, A A, Murugesan, G, Zhang, L, Bhatt, D L, Kottke-Marchant, K. 2012. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. In International journal of laboratory hematology, 34, 473-83. doi:10.1111/j.1751-553X.2012.01420.x. https://pubmed.ncbi.nlm.nih.gov/22574824/
5. Läer, Katharina, Vennemann, Marielle, Rothämel, Thomas, Klintschar, Michael. 2013. Association between polymorphisms in the P2RY1 and SSTR2 genes and sudden infant death syndrome. In International journal of legal medicine, 127, 1087-91. doi:10.1007/s00414-013-0887-7. https://pubmed.ncbi.nlm.nih.gov/23828624/
6. Light, Kathleen C, Agarwal, Neeraj, Iacob, Eli, Bateman, Lucinda, Light, Alan R. 2013. Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome. In Psychoneuroendocrinology, 38, 2983-95. doi:10.1016/j.psyneuen.2013.08.008. https://pubmed.ncbi.nlm.nih.gov/24054763/